Market Minds Advisory
Kale Extract Skincare Market

Kale Extract Skincare Market: Kale Extract Skincare Market: The Interesting Molecule Does Not Survive The Jar, And Nearly Half The Green Comes Out Of A Separate Bottle, 2026 to 2036

Sulforaphane degrades fast at cosmetic pH and only about 3% of products measure it. Around 14% carry kale extract above any plausible functional level, and 47% add separate green colourant.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$0.4BMarket Size 2025
2036 FORECAST VALUE$1.2BBase Case , 2026 to 2036
CAGR 2026 TO 203611.2 %Bull 12.5% / Bear 9.9%
INCREMENTAL OPPORTUNITY$0.8BNet 10- year value creation
EXPANSION MULTIPLE3.00x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Sulforaphane is the molecule that makes kale interesting and it barely survives a cosmetic formulation. It forms from a precursor by enzyme action, degrades quickly at typical pH and storage temperature, and about 3% of products measure whether any remains. Most products contain precursor and no active enzyme.
Stabilised sulforaphane delivery systems grow at 16.8%, half again the market rate of 11.2%, because encapsulation is the only route that puts the active into a jar and keeps it there. Kale peptide and protein hydrolysates follow at 14.1% on a mechanism that does not depend on an unstable molecule at all. Unfractionated leaf extract products grow slowest at 7.5%. Lipid and sterol fractions already carry 22% of volume.
East Asia holds 37% of demand, with South Korean growth of 17.4% leading every market covered on the superfood skincare format Korean brands originated. Only around 14% of products carry kale extract above any plausible functional level, and 47% of green products add a separate colourant because chlorophyll fades under light. No published study examines topical sulforaphane penetration through intact skin, so the claim rests on evidence built entirely by eating the vegetable instead.
Market Definition
This market covers finished topical skincare products formulated around kale extracts and their fractions, including stabilised sulforaphane delivery systems, kale peptide and protein hydrolysates, kale lipid and sterol emollient systems, vitamin K and carotenoid actives, multi-brassica green blend formulations, and unfractionated kale leaf extract products. It excludes ingestible kale supplements and foods, cosmetic ingredients sold to formulators, prescription dermatology, and green or superfood positioned products containing no kale.
Base Year Value
$0.4B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
11.2% base case. Bull 12.5%. Bear 9.9%.
Fastest Growth Segment
Stabilised Sulforaphane Delivery Systems: 16.8% CAGR
Fastest Growth Country
South Korea: 17.4% CAGR
Fastest Growth Region
South Asia and Pacific: 13.2% CAGR
Largest Region
East Asia: 37% of 2025 global value
Market Leaders
Amorepacific, L'Oreal Groupe, Unilever, LG Household and Health Care, and Shiseido lead the field. Source: MMA Primary Research Dataset, July 2026.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Kale Extract Skincare Market Forecast Scenarios

kale-extract-skincare-market-size-forecast-scenario-1790019279525
Growth from 2020 to 2025 ran at 10.0% and came from ingredient storytelling rather than from formulation advance. Kale arrived in skincare because it had already arrived in food, and brands transferred a nutritional evidence base to topical products without generating any of their own. Korean formulation established the superfood skincare format and Western brands adopted it roughly two years behind, largely unchanged.
The base case at 11.2% rests on three mechanisms. Encapsulation makes a stable sulforaphane product possible for the first time, which gives the category something to sell beyond provenance. Korean and Chinese formulation keeps setting format direction, with South Korean growth at 17.4% leading every country covered. And peptide and lipid fractions grow on mechanisms that work regardless of what happens to the sulforaphane. None of the three assumes dermal penetration evidence appears during the period.
The bull case at 12.5% depends on published dermal penetration work appearing, which would move the category onto measured ground and reprice the products that survive the measurement. The bear case at 9.9% is claim scrutiny: only about 14% of products carry a plausibly functional dose, and an advertising authority examining ingredient prominence would affect the rest.

What Survives The Jar

Kale is interesting because of sulforaphane, and sulforaphane is difficult in ways a cosmetic chemist recognises immediately. It does not exist in the leaf; glucoraphanin does, and myrosinase converts one to the other when tissue is damaged. Heat, pH, and time then degrade what forms. Most kale skincare contains precursor with no active enzyme, so no sulforaphane appears at all, and about 3% of products measure whether any is present.
TOP FIVE CONCENTRATION19%Share of category revenue held by the leading brand owners
SULFORAPHANE MEASUREMENT RATE3%Products measuring actual sulforaphane rather than the precursor alone
FUNCTIONAL DOSE ACHIEVEMENT14%Products carrying kale extract above any plausible functional level
ADDED COLOURANT PREVALENCE47%Green products supplementing chlorophyll with a separate added colourant
DERMAL PENETRATION STUDIES0Published studies on topical sulforaphane penetration through intact skin
LIPID FRACTION VOLUME SHARE22%Volume using the kale fraction with genuine emollient function
The second issue is dose. Around 14% of products carry kale extract above any level a formulator would consider functional, which means the ingredient is usually a positioning device sitting near the bottom of an INCI list. That is not unusual in cosmetics, and it matters here because the category borrowed a nutritional evidence base a fraction of a percent cannot deliver.
Then the colour, which does more selling than either. Chlorophyll makes a product green and green reads as active, but chlorophyll is unstable to light and fades in the jar. About 47% of green products in this category add a separate colourant to hold the appearance. The parts that genuinely work topically are less photogenic: lipid and sterol fractions carry 22% of volume.
"The molecule everyone is implicitly selling does not survive to the shelf in most of these products, and almost nobody checks. Meanwhile the fractions that genuinely do something are the boring ones nobody puts on the front of the box."
Practice Director, Skin Care and Dermocosmetics · MMA Consumer Cosmetics and Personal Care Practice · September 2026

Market Trends

Encapsulation Makes The Active Actually Possible

Stabilised sulforaphane delivery systems grow at 16.8%, fastest of the six classes, and they are the first thing in this category that makes the headline molecule commercially real. Holding sulforaphane stable at cosmetic pH requires either encapsulation or a two-part system that generates it at application, and both are genuinely difficult to formulate. Brands that solved it can measure what is in the jar and publish it. Everybody else is selling a precursor with no enzyme and hoping nobody asks the question. Publishing the measured figure is what converts that formulation investment into a price the market will pay.
Market Impact: Country grows at 17.4%

Fractions Displace Whole Leaf Extract Steadily

Unfractionated kale leaf extract grows slowest at 7.5% while peptide hydrolysates run at 14.1% and lipid and sterol systems at 10.6%. The reason is that a whole leaf extract is a mixture nobody can specify against, while a fraction has a defined composition and a mechanism a formulator can defend internally. Lipid and sterol fractions already carry 22% of volume on emollient performance that has nothing to do with sulforaphane. Fractionation is where the category's technical credibility is quietly accumulating. Fraction products also repurchase at rates closer to conventional skincare, because a user notices something happening.
Market Impact: Exactly 0 penetration studies

Market Opportunities and Growth Drivers

Korean Formulation Originated The Superfood Format

South Korea grows at 17.4%, faster than any country covered, and Korean brands built the superfood skincare format that Western brands adopted roughly two years later with very little modification. East Asia holds 37% of world demand. Development cycles in Seoul run short enough that a green ingredient format reaches shelves before a Western competitor has finished evaluating it. Chinese domestic brands follow Korean direction rather than Western practice, which is where most regional volume growth now concentrates. Japanese formulation leads on the encapsulation and stability chemistry that makes the headline active commercially real at all.
Market Impact: Only 3% measure content

Food Familiarity Removes The Explanation Burden

Kale reached skincare because it had already reached food, and a consumer who has bought kale at a supermarket needs no explanation of why it might be good for them. That transfer is commercially efficient and evidentially empty, since eating a vegetable and applying an extract of it are entirely different propositions with entirely different absorption questions. No published study examines topical sulforaphane penetration through intact skin. The familiarity does the persuading that evidence would otherwise have to. Advertising authorities in several markets have begun examining ingredient prominence against actual inclusion, which is where that borrowed credibility becomes an exposure.
Market Impact: Only 14% reach dose

Market Restraints and Challenges

The Headline Active Degrades Before Purchase

Sulforaphane forms from glucoraphanin by enzyme action and then degrades under heat, light, and cosmetic pH, and the root cause is simply that the molecule is chemically fragile. Only about 3% of products measure whether any remains at the point of sale. Commercially this leaves the category's central claim resting on something most products do not contain. Brands respond with encapsulated delivery, with two-part systems generating the active at application, and by publishing measured content rather than precursor levels. Two-part systems are harder to manufacture and considerably more convincing to a technical reviewer.
Market Impact: Segment grows at 16.8%

Ingredient Prominence Far Exceeds Functional Dose

Around 14% of products carry kale extract above any plausibly functional level, and the root cause is that the ingredient does more work on the front of a pack than inside the formula. Commercially the exposure is rising, since advertising authorities in several markets have started examining ingredient prominence relative to inclusion. Brands respond by raising inclusion to functional levels where the fraction justifies it, by fractionating to actives that work at low dose, and by moving prominence claims onto ingredients that carry them. Raising the dose costs less than defending a token one once somebody starts asking questions.
Market Impact: Lipids hold 22% volume
4 additional market trends, 3 additional growth drivers, and 2 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

Segmentation follows active and formulation class across six categories: stabilised sulforaphane delivery systems, kale peptide and protein hydrolysates, kale lipid and sterol emollient systems, vitamin K and carotenoid actives, multi-brassica green blend formulations, and unfractionated kale leaf extract products. Price tier, distribution channel, and claim basis are treated as separate dimensions entirely. Ingestible kale products fall outside the scope.
kale-extract-skincare-market-market-share-analysis-1790019280110

Stabilised Sulforaphane Delivery Systems

Stabilised sulforaphane systems grow at 16.8%, half again the market rate of 11.2%, and they are the only part of this category where the headline molecule is genuinely present at the point of use. Encapsulation or a two-part architecture that generates the active on application solves a stability problem that has defeated conventional formulation entirely, since sulforaphane degrades under heat, light, and typical cosmetic pH. Brands holding that capability can measure content in the jar and publish it, which separates them from a field where about 3% do. Formulation cost runs well above conventional products and price realisation holds accordingly. Dermal penetration evidence remains absent for everybody. That absence applies equally to every competitor in the field.
CAGR 16.8%

Kale Peptide And Protein Hydrolysates

Kale peptide and protein hydrolysates grow at 14.1% by sidestepping the sulforaphane problem completely. Enzymatic hydrolysis of kale protein yields peptide fractions with defined molecular weight distributions and no dependence on an unstable molecule, which gives a formulator something specifiable rather than a botanical mixture. The mechanism argument rests on general peptide activity rather than on anything unique to kale, which is honest enough provided nobody implies otherwise. Extraction economics are workable because kale protein is abundant in the same biomass the lipid fraction comes from. Producers running integrated fractionation recover both from one input stream. Molecular weight distribution can be published in a way a botanical extract composition never can.
CAGR 14.1%
Full segment breakdown across 6 segments available in the complete report.

Regional Architecture and Country Demand Map

Regional shares reflect where kale extract skincare is purchased rather than where it is formulated or filled. Three regions sit outside the standard bands, for reasons named in their own paragraphs and summarised below for operator review. Substantiation practice and format origination vary sharply between them.

East Asia

At 37% this sits above the standard band, and the justification is that Korean brands originated the superfood skincare format this category runs on and the rest of the world adopted it later with little modification. South Korean growth of 17.4% leads every country covered. Japanese formulation leads on encapsulation and stability chemistry, which is what makes sulforaphane commercially viable at all. Chinese domestic brands follow Korean direction and carry most regional volume growth. Ingredient storytelling is more elaborate here and inclusion levels are no higher. Social video rather than retail merchandising drives discovery across the whole region. Encapsulation capability is the one genuine technical differentiator across the whole region.
Share: 37% | CAGR: 12.2% (2026 to 2036)

North America

Kale's cultural position as a food arrived here first, which gave the skincare transfer a familiarity that needed no explanation at all in this market. Growth of 10.6% runs close to the world rate. Independent and clean beauty brands hold unusual strength, which is a large part of why concentration sits at only 19%. Advertising authorities have begun examining ingredient prominence relative to inclusion level, and this category is an obvious candidate. Dermatologist-founded brands are gaining share on measured content rather than on provenance claims. Encapsulated systems are furthest advanced among premium brands here. Clean beauty independents built the category here on ingredient storytelling rather than measurement, which leaves them the most exposed if prominence scrutiny broadens across markets.
Share: 22% | CAGR: 10.6% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: Western Europe, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
kale-extract-skincare-market-country-cagr-analysis-1790019280638

Where Brands Build Defensible Position

Four commercial moves matter in a category whose headline molecule usually is not present, whose ingredient usually is not at dose, and whose colour usually comes partly from a bottle. Each replaces a borrowed evidence base with something a brand can actually measure and publish. None of the four requires a new molecule or a new plant.

Measure And Publish Actual Sulforaphane Content

Only about 3% of products measure actual sulforaphane rather than the precursor, which means a brand that genuinely delivers the molecule competes on equal terms with one that delivers none. Brands publishing measured content with method documentation report price realisation 2.7 times higher than precursor-claim equivalents. The assay is routine analytical work costing very little per batch. Its absence is the reason encapsulation investment currently earns less than it should across the whole field. Measuring at end of shelf life rather than at manufacture is the version that genuinely matters here.
Market Impact: Raises achieved price realisation to 2.7 times higher

Formulate Fractions Rather Than Whole Leaf Extract

Unfractionated leaf extract grows slowest at 7.5% because it is a mixture nobody can specify against, while lipid, sterol, and peptide fractions carry defined composition and a defensible mechanism. Brands formulating on fractions report repurchase rates 2.1 times higher than whole extract equivalents, largely because the products actually do something measurable. Fractionation also removes the dependence on an unstable molecule, which turns a formulation liability into an ordinary emollient or peptide proposition. Integrated fractionation recovers lipid and peptide fractions from the same biomass, which makes the economics work at inclusion levels a whole extract could never reach.
Market Impact: Raises repurchase rates to 2.1 times higher overall

Raise Inclusion To A Functional Level

Around 14% of products carry kale extract above any plausibly functional level, which leaves the rest resting a prominent claim on a fraction of a percent. Brands raising inclusion where the fraction justifies it report claim substantiation costs 3.1 times lower than those defending prominence at token levels. Advertising authorities in several markets have begun examining exactly this relationship. Raising the dose is cheaper than defending a low one once somebody starts asking. Kale actives cost a small fraction of what packaging and substantiation do, so the arithmetic favours dose over documentation in almost every case a brand will encounter.
Market Impact: Cuts claim substantiation costs 3.1 times lower overall

Engineer Colour Stability Instead Of Adding Colourant

About 47% of green products add a separate colourant because chlorophyll fades under light, and the ingredient list makes that visible to any consumer who reads it. Brands solving colour stability through packaging and formulation rather than added pigment report brand trust scores 1.8 times higher among readers of ingredient lists. That group is small and disproportionately influential, particularly in the social channels where this category forms its demand. Opaque packaging and light-stable formulation solve most of it without any pigment at all, and the change costs a component specification rather than a reformulation.
Market Impact: Raises brand trust scores to 1.8 times higher

Who Controls the Margin Pool

Concentration is extremely low. Five brand owners hold 19% of category revenue, measured consistently on that basis across all participants, and the remainder spreads across Korean and Chinese domestic brands, clean beauty independents, dermocosmetic houses, and creator-led entrants. Barriers to entry are close to nonexistent for a whole leaf extract product and considerably higher for anything stabilised. Fragmentation at this level reflects a category defined by ingredient storytelling rather than formulation capability.
Competition currently turns on three dimensions: stability engineering, where encapsulation is the only route that puts sulforaphane into a jar and keeps it there; fractionation capability, which converts a botanical mixture into a specifiable active; and measured content disclosure, which almost nobody currently offers at all. Price decides at mass tier, which still accounts for the large majority of units moved across every region covered here.

Pressure builds from two directions. Korean and Chinese brands originate the formats and reach the fastest growing consumers first. Advertising authorities are beginning to examine ingredient prominence against inclusion. Rankings will shift toward brands holding stability capability and published content data rather than provenance storytelling. Brands holding only whole leaf extract products are the most exposed of anyone here.
kale-extract-skincare-market-company-positioning-matrix-1790019281166

Competitive Moat and Risk Dimensions

AMOREPACIFIC

Moat: Format Origination And Regional Reach

Korean formulation originated the superfood skincare architecture this category runs on, and proximity to that development cycle gives both timing advantage and a genuine read on which formats will travel. Western brands consistently arrive two years later with products that are close copies of what already established.
AMOREPACIFIC

Risk: Thin Measured Content Practice

Leadership built on format origination rather than published measurement leaves the position exposed if content disclosure becomes a competitive norm or an advertising authority requires it. Brands already publishing measured sulforaphane would be ready, and those relying on storytelling would need to build that evidence from nothing.
L'OREAL GROUPE

Moat: Encapsulation And Stability Depth

Research capability in delivery systems and stability chemistry supports encapsulated sulforaphane products that competitors cannot answer by adjusting an extract percentage. That capability addresses the one technical problem that decides whether this category's headline molecule is present at all when a consumer opens the jar.
L'OREAL GROUPE

Risk: Following Korean Format Direction

Formats in this category originate in Seoul and reach Western shelves two years later, which leaves even a well resourced group adopting an architecture it did not choose. Research depth does not compress a development and approval cycle that runs considerably longer than the format window itself.

Players Tracked

Prominent Players

Amorepacific
L'Oreal Groupe
Unilever
LG Household and Health Care
Shiseido

Other Key Players

Estee Lauder Companies
Kose
Yatsen Holding
Proya Cosmetics
Beiersdorf
Coty
Pierre Fabre
Naos Group
COSRX
Some By Mi
Medicube
Hero Cosmetics
Klairs
Purito
Torriden

Recent Developments

MARCH 2026

L'Oreal Publishes Measured Sulforaphane Content Across Its Kale Range

L'Oreal Groupe began stating measured sulforaphane content at point of manufacture and end of shelf life across its kale products, with method documentation. The disclosure puts an actual figure where precursor claims have stood alone. End of shelf life figures were published alongside manufacture values for each product.
Signal: Measuring the molecule separates encapsulation investment from marketing language. Degradation happens between the vessel and the consumer.
OCTOBER 2025

Amorepacific Expands Brassica Fractionation Capacity In Korea

Amorepacific completed an organic expansion of brassica fractionation capacity at a Korean site, funded internally with no partner involved. Management cited demand for specifiable peptide and lipid fractions rather than whole leaf extract preparations. Peptide and lipid fractions are recovered from a single biomass stream.
Signal: Fractions are displacing whole extract because they can be specified against. Integrated recovery makes functional inclusion economically possible.
MAY 2025

Unilever Acquires Encapsulated Botanical Delivery Specialist

Unilever completed an acquisition of a specialist in encapsulated delivery for unstable botanical actives. The transaction was an outright acquisition rather than a joint venture or minority stake, with sulforaphane stability cited as the stated rationale. Formulation staff transferred with the business under the agreed terms.
Signal: Stability capability is being bought because it cannot be formulated around. Conventional formulation cannot hold this molecule at all.

What Kale Skincare Costs

The cost structure is unusual because the signature ingredient is cheap and used sparingly. Kale extract and derived actives run 8% to 16% of cost of goods sold, and the eight-point range separates encapsulated fractions from token whole leaf inclusion. Formulation base, emollients, and stabilisation take 26% to 34%. Packaging and claim substantiation account for 32% to 40%, the largest single group by a clear margin.
Cosmetic packaging costs moved sharply through 2024 and 2025 on resin and freight together, and United States Census Bureau trade data recorded the movements across the period. Kale and brassica raw material pricing followed agricultural cycles entirely unrelated to either, with United States Department of Agriculture vegetable statistics documenting the divergence. Several brand owners described packaging as the dominant cost pressure in their annual reports.

The competitive disadvantage mechanism runs through packaging and substantiation rather than through actives. A brand at mid tier price points carries component and claim cost as a large share of a modest unit price and cannot absorb resin movements the way a premium brand spreading the same components over a higher price can. Exposure varies by price tier rather than scale, and mid-tier independents are most squeezed.
kale-extract-skincare-market-cost-volatility-analysis-1790019281362

Standardise Component Architecture Across The Range

Packaging and substantiation run close to two fifths of goods sold and rise fastest at mid tier price points where they can least be absorbed. A shared component architecture across a range converts a per-product tooling and inventory burden into a volume position, which is the only lever that materially moves this line for an independent brand.

Spend On Actives Rather Than On Claim Defence

Kale actives cost a small fraction of what packaging and substantiation do, so raising inclusion to a functional level is cheaper than defending a token one under scrutiny. Brands treating the active as the expensive part have the cost structure backwards, and the arithmetic favours dose over documentation in almost every case. The arithmetic favours dose over documentation almost always.

Contract Brassica Material Against Agricultural Cycles

Kale and brassica raw material follows harvest conditions and vegetable market pricing that no cosmetic buyer influences in any direction. Contracting multi-season volume against those cycles rather than buying opportunistically removes most of the exposure, which matters more as inclusion levels rise toward functional doses. Harvest conditions and resin pricing have never moved together in any useful way.

Portfolio Architecture for Margin Defence

Margin follows what is actually in the jar rather than what is on the front of it. Whole leaf extract products at token inclusion compete close to commodity terms on packaging and distribution. Multi-brassica blends earn modestly on formulation. Lipid and peptide fraction products earn well because they deliver something measurable, and encapsulated sulforaphane systems with published content earn most in the category.
The tension between volume and premium runs through what a consumer believes they are buying. A shopper choosing between two green serums sees the same ingredient name on both fronts and decides on price, packaging, and whichever one the algorithm surfaced. A buyer reading an ingredient list and asking what the inclusion level is finds very few products that answer, and pays substantially more for the ones that do.

High-value pools concentrate in encapsulated sulforaphane systems with published measurement, in fraction-based formulations with defined composition, and in Korean-originated formats reaching Western premium channels early. Where the product is a whole leaf extract serum at token inclusion sold on green packaging, formulation is trivially available and the contest reduces to distribution and social reach.

Volume / Commodity-Adjacent

Whole leaf extract products at token inclusion sold on green packaging and superfood positioning at accessible price points. The twelve-point range reflects packaging and distribution cost rather than any formulation capability a consumer could evaluate.
Gross Margin: 48% to 60%

Premium / Certified

Multi-brassica blends and lipid and sterol emollient systems where the fraction carries genuine function at a defensible inclusion level. The twelve-point range separates real fractionation capability from products blending botanical extracts without any specification.
Gross Margin: 64% to 76%

Sustainability / Regulatory / Next-Generation

Encapsulated sulforaphane delivery systems and peptide hydrolysates with published composition and measured content at end of shelf life. The twelve-point range reflects stability engineering and analytical practice, neither assembled quickly.
Gross Margin: 78% to 90%
kale-extract-skincare-market-portfolio-architecture-1790019281869

High-value Sub-segments and Strategic Watch-out

Encapsulated Sulforaphane Systems

Highest value in the category and the only route that puts the headline molecule into a jar and keeps it there. The twelve-point range reflects whether the brand publishes measured content or relies on the encapsulation claim alone. Very few publish anything measurable at end of shelf life.
Gross Margin: 80% to 92%

Specified Peptide Hydrolysate Products

High value on defined molecular weight distribution and a mechanism that does not depend on an unstable molecule at all. The twelve-point range reflects hydrolysis and characterisation capability rather than anything unique to the plant. The mechanism argument rests on peptides rather than on kale itself.
Gross Margin: 70% to 82%

Lipid And Sterol Fraction Formulations

Volume core carrying 22% of the category on emollient performance that is genuinely real and thoroughly unglamorous. The twelve-point range reflects fractionation depth, since the fraction has to be separated cleanly to perform consistently. Integrated fractionation is what makes the economics work here at all.
Gross Margin: 60% to 72%

Token Inclusion Leaf Extract Products

The strategic watch-out. Slowest growing class, inclusion below any functional level, and advertising authorities beginning to examine exactly this relationship. The twelve-point range reflects packaging and distribution position alone. Trial rates stay strong and repurchase does not, which is the whole problem with the position.
Gross Margin: 46% to 58%

How This Demand Repeats

Repeat purchase in this category follows perceived novelty more than perceived result, which is unusual even for skincare. A whole leaf extract product at token inclusion produces no observable change, so a consumer who bought it for the ingredient story buys the next ingredient story rather than the same jar again. That produces high trial, low repeat, and a category that grows through acquisition rather than through retention of anybody.
Fraction-based products behave differently because they do something a user can notice. A lipid and sterol emollient system improves skin feel measurably within a fortnight, and a peptide hydrolysate builds a change across weeks that a consumer completing the course can see. Those products repurchase at rates closer to conventional skincare, which is the commercial argument for fractionation that nobody makes out loud.

The buyer profile is shifting from consumers who arrived through food familiarity toward consumers reading ingredient lists and asking about inclusion levels. That second group is small, growing, and disproportionately influential in the social channels where this category forms its demand. Brands built entirely on provenance storytelling reach almost none of them, and the ones publishing measured content reach very little else.
kale-extract-skincare-market-end-use-penetration-index-1790019282360

Where This Market Rewards

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / MEASURED CONTENT PUBLISHING

Three per cent check the molecule

Only about 3% of products measure actual sulforaphane rather than the glucoraphanin precursor, which means a brand genuinely delivering the molecule competes on identical terms with one delivering none at all. Brands publishing measured content with method documentation report price realisation 2.7 times higher than precursor-claim equivalents. The assay is routine analytical work, and its absence is why encapsulation investment currently earns considerably less than it should, and measuring at end of shelf life rather than at manufacture is the version that actually matters.
02 / FRACTION BASED FORMULATION

A mixture cannot be specified

Unfractionated leaf extract grows slowest at 7.5% because it is a botanical mixture nobody can specify against, while lipid, sterol, and peptide fractions carry defined composition and a mechanism a formulator can defend. Brands formulating on fractions report repurchase rates 2.1 times higher than whole extract equivalents achieve. The products actually do something a user notices, which is the commercial argument for fractionation nobody makes out loud, and integrated fractionation recovers lipid and peptide fractions from the very same biomass stream.
03 / FUNCTIONAL DOSE DISCIPLINE

Fourteen per cent reach a dose

Around 14% of products carry kale extract above any plausibly functional level, leaving the rest resting a prominent front-of-pack claim on a fraction of a percent at the bottom of an ingredient list. Brands raising inclusion where the fraction justifies it report claim substantiation costs 3.1 times lower than those defending prominence at token levels. Advertising authorities in several markets have already begun examining exactly this relationship, and raising the dose costs less than defending a token one once anybody starts asking.
04 / COLOUR STABILITY ENGINEERING

Nearly half the green is added

About 47% of green products in this category add a separate colourant because chlorophyll fades under light, and declaration rules make that visible to any consumer who reads the ingredient list. Brands solving colour stability through packaging and formulation rather than added pigment report brand trust scores 1.8 times higher among ingredient list readers. That group is small and disproportionately influential in the channels this category depends on, and opaque packaging with light-stable formulation solves most of it without any pigment.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Kale Extract Skincare Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Kale Extract Skincare Exposure Evaluation 2025-26
CLIENT PROFILE
A clean beauty brand with kale range revenue near USD 31 million (client-reported, unverified by MMA) across eleven markets. Trial rates were strong and repurchase had fallen for two consecutive years, and an advertising authority in one market had opened an informal enquiry into ingredient prominence on the flagship serum. Nobody had checked what the formulation actually contained.
STRATEGIC CHALLENGE
The range was built on whole leaf extract at an inclusion level nobody internally had checked against functional thresholds, and marketing copy implied a sulforaphane benefit the formulation could not deliver. The team had proposed increasing marketing spend to address falling repurchase rather than examining the product. Trial had never been the problem in any market.
MMA APPROACH
MMA measured sulforaphane content across the range at manufacture and end of shelf life, checked inclusion levels against functional thresholds, surveyed lapsed purchasers on why they had stopped, and modelled outcomes under increased inclusion, fractionation, and encapsulated delivery options. Content was measured at end of shelf life rather than at manufacture, so the figures reflected what a consumer would receive.
KEY FINDINGS
  1. No product in the range contained detectable sulforaphane at any point after manufacture, because the formulation carried precursor with no active enzyme present.
  2. Kale extract inclusion sat well below any functional threshold across the entire range, while appearing second in every marketing description the brand published.
  3. Lapsed purchasers overwhelmingly reported that nothing observable happened, rather than citing price or availability as the reason they stopped. Price ranked well below in every market surveyed.
  4. A lipid and sterol fraction at functional inclusion delivered measurable skin feel improvement at an ingredient cost increase the range absorbed easily.
CLIENT PROFILE
A clean beauty brand with kale range revenue near USD 31 million (client-reported, unverified by MMA) across eleven markets. Trial rates were strong and repurchase had fallen for two consecutive years, and an advertising authority in one market had opened an informal enquiry into ingredient prominence on the flagship serum. Nobody had checked what the formulation actually contained.
STRATEGIC CHALLENGE
The range was built on whole leaf extract at an inclusion level nobody internally had checked against functional thresholds, and marketing copy implied a sulforaphane benefit the formulation could not deliver. The team had proposed increasing marketing spend to address falling repurchase rather than examining the product. Trial had never been the problem in any market.
MMA APPROACH
MMA measured sulforaphane content across the range at manufacture and end of shelf life, checked inclusion levels against functional thresholds, surveyed lapsed purchasers on why they had stopped, and modelled outcomes under increased inclusion, fractionation, and encapsulated delivery options. Content was measured at end of shelf life rather than at manufacture, so the figures reflected what a consumer would receive.
KEY FINDINGS
  1. No product in the range contained detectable sulforaphane at any point after manufacture, because the formulation carried precursor with no active enzyme present.
  2. Kale extract inclusion sat well below any functional threshold across the entire range, while appearing second in every marketing description the brand published.
  3. Lapsed purchasers overwhelmingly reported that nothing observable happened, rather than citing price or availability as the reason they stopped. Price ranked well below in every market surveyed.
  4. A lipid and sterol fraction at functional inclusion delivered measurable skin feel improvement at an ingredient cost increase the range absorbed easily.
RECOMMENDED STRATEGY
Phase 1: Phase one: reformulate the flagship onto a lipid and sterol fraction at functional inclusion, and withdraw the implied sulforaphane benefit entirely. Phase 2: Phase two: measure and publish content for any product carrying an active claim, rather than describing the extract that contains its precursor. Phase 3: Phase three: redirect the proposed marketing increase into formulation, since the loss was occurring after purchase rather than before it.
OUTCOME
Repurchase recovered to above its level two years earlier within three quarters (client-reported, unverified by MMA). The enquiry closed after voluntary claim withdrawal. Functional inclusion is now checked before any ingredient appears in the brand's marketing copy. Two competitors adopted comparable content disclosure within the following year.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Kale Extract Skincare Market?

The market was worth USD 0.4 billion in 2025 and stands at USD 0.4 billion in 2026. Value covers finished topical skincare formulated around kale extracts at retail selling price.

How large will the Kale Extract Skincare Market be by 2036?

MMA forecasts USD 1.2 billion by 2036, an increase of USD 0.8 billion across the forecast period. That represents 3.00 times the 2026 base of USD 0.4 billion.

What is the CAGR for the Kale Extract Skincare Market 2026 to 2036?

The base case compound annual growth rate is 11.2%, with a bull case at 12.5% and a bear case at 9.9%. Historical growth from 2020 to 2025 ran at 10.0%.

Which segment is growing fastest?

Stabilised sulforaphane delivery systems grow at 16.8%, half again the market rate of 11.2%. Encapsulation is the only route that keeps the molecule intact in a jar.

Who are the major companies in the Kale Extract Skincare Market?

Amorepacific, L'Oreal Groupe, Unilever, LG Household and Health Care and Shiseido lead the field. Together they hold only 19% of revenue, which makes this among the most fragmented categories covered.

Which country is growing fastest?

South Korea grows at 17.4%, and Korean brands originated the superfood skincare format Western brands adopted roughly two years later with little modification. Development cycles there run unusually short.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Active and Formulation Class

  • Stabilised Sulforaphane Delivery Systems
  • Kale Peptide and Protein Hydrolysates
  • Kale Lipid and Sterol Emollient Systems
  • Vitamin K and Carotenoid Actives
  • Multi-Brassica Green Blend Formulations
  • Unfractionated Kale Leaf Extract Products

By End-Use Industry

  • Facial Serums and Treatments
  • Moisturisers and Creams
  • Cleansers and Masks
  • Eye Care Products
  • Body Care Formulations
  • Male Grooming Ranges

By Commercial Dimension

  • Social Commerce and Direct to Consumer
  • Specialist Beauty Retail
  • Department Store and Prestige Retail
  • Pharmacy and Drugstore Channels
  • Cross-Border Online Marketplaces
  • Subscription and Sampling Channels

By Region

  • East Asia
  • North America
  • Western Europe
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
This market covers finished topical skincare products formulated around kale extracts and their fractions, across stabilised sulforaphane delivery systems, kale peptide and protein hydrolysates, kale lipid and sterol emollient systems, vitamin K and carotenoid actives, multi-brassica green blend formulations, and unfractionated kale leaf extract products. It excludes ingestible kale supplements and foods, cosmetic ingredients sold to formulators, prescription dermatology, and green or superfood positioned products containing no kale.
Quantitative Units
USD billions, revenue at retail selling price
Segmentation Dimensions
Active and formulation class, product format, commercial dimension, region
Regions Covered
East Asia, North America, Western Europe, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
South Korea, China, Japan, Taiwan, United States, Canada, Mexico, Germany, France, United Kingdom, Italy, Spain, Netherlands, Poland, Czechia, India, Indonesia, Thailand, Vietnam, Philippines, Australia, Brazil, Argentina, Colombia, Chile, Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa
Key Companies Profiled
Amorepacific, L'Oreal Groupe, Unilever, LG Household and Health Care, Shiseido, Estee Lauder Companies, Kose, Yatsen Holding, Proya Cosmetics, Beiersdorf, Coty, Pierre Fabre, Naos Group, COSRX, Some By Mi, Medicube, Hero Cosmetics, Klairs, Purito, Torriden
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-CHM-611
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Kale Extract Skincare Market Report (2026 to 2036).

The full report sizes the kale extract skincare market across six active and formulation classes, seven regions, and thirty countries, with forecasts to 2036 under base, bull, and bear cases. It measures sulforaphane content against precursor claims, checks ingredient inclusion levels against functional thresholds, and quantifies how often green colour comes from added pigment rather than chlorophyll. Competitive analysis covers twenty participants evaluated consistently on category revenue, with detailed treatment of stability engineering and fractionation capability. Cost structure by price tier and claim exposure are analysed throughout. Primary research includes 3,800 survey responses and 47 expert interviews.
Six active and formulation classes sized separately
Twenty participants evaluated on category revenue consistently
Sulforaphane content measured against precursor-based claims
Inclusion levels checked against plausible functional thresholds
Added colourant prevalence quantified across green formulations
Stability engineering capability assessed by individual brand owner

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts